What Vedrop contains
- The active substance is tocofersolan. Each ml of solution contains 50 mg of d-alpha-tocopherol in the form of tocofersolan, corresponding to 74.5 IU of tocopherol.
- The other ingredients are: potassium sorbate, sodium methyl parahydroxybenzoate (E219), sodium propyl parahydroxybenzoate (E217), glycerol, disodium phosphate dodecahydrate, concentrated hydrochloric acid, purified water.
What Vedrop looks like and contents of the pack
Vedrop is a slightly viscous pale yellow oral solution in a brown glass bottle. The bottles contain 10 ml, 20 ml or 60 ml of oral solution. Each box contains one bottle and one oral syringe (a 1 ml syringe with a 10 ml or 20 ml bottle, a 2 ml syringe with a 60 ml bottle).
Marketing Authorisation Holder and Manufacturer
Orphan Europe S.A.R.L.
Immeuble ?Le Wilson?
70 avenue du General de Gaulle
92800 Puteaux
France
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
BelgiqueBelgiëBelgien Orphan Europe Benelux Koning Albert I, Iaan 48 bus 3 B-1780 Wemmel TélTel 32 2 46101 36 LuxembourgLuxemburg Orphan Europe Benelux Koning Albert I, Iaan 48 bus 3 B-1780 Wemmel BelgiqueBelgiëBelgien TélTel 32 2 46101 36
Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Te. 49 6074 914090 Magyarország Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Németország Tel 49 6074 914090
eská republika Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Nmecko Tel 49 6074 914090 Malta Orphan Europe SARL Immeuble Le Wilson 70 avenue du Général de Gaulle F-92800 Puteaux Franza Tel 33 1 47 73 64 58
Danmark Orphan Europe AB Banérgatan 37 S-115 22 Stockholm vedija Tel 46 8 545 80 230 Nederland Orphan Europe Benelux Koning Albert I Iaan 48 bus 3 B-1780 Wemmel België Tel 32 2 46101 36
Deutschland Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Tel 49 06074 914090 Norge Orphan Europe AB Banérgatan 37 S-115 22 Stockholm vedija Tel 46 8 545 80 230
Eesti Orphan Europe AB Banérgatan 37 S-115 22 Stockholm Rootsi Tel 46 8 545 80 230 Österreich Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Deutschland Tel 49 6074 914090
Polska Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Niemcy Tel 49 6074 914090 Orphan Europe SARL Immeuble Le Wilson 70 avenue du Général de Gaulle F-92800 Puteaux 33 1 47 73 64 58
España Orphan Europe, S.L. Gran via de les Cortes Catalanes, 649 Despacho, n1 E-08010 Barcelona Tel 34 93 342 51 20 Portugal Orphan Europe, S.L. Gran via de les Cortes Catalanes, 649 Despacho, n1 E-08010 Barcelona Espanha Tel 34 93 342 51 20
France Orphan Europe SARL Immeuble Le Wilson 70 avenue du Général de Gaulle F-92800 Puteaux Tél 33 1 47 73 64 58 România Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Germania Tel 49 6074 914090
Slovenija Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Nemija Tel 49 6074 914090 Ireland Orphan Europe UK Ltd. Isis House, 43 Station Road Henley-on-Thames Oxfordshire RG9 1AT, UK United Kingdom Tel 44 1491 414333
Ísland Orphan Europe AB Banérgatan 37 S-115 22 Stockholm vedija Tel 46 8 545 80 230 Slovenská republika Orphan Europe Germany GmbH Max-Planck Str. 6 D-63128 Dietzenbach Nemecko Tel 49 6074 914090
Italia Orphan Europe Italy Srl Via Cellini 11 I-20090 Segrate Milano Tel 39 02 26 95 01 39 SuomiFinland Orphan Europe AB Banérgatan 37 S-115 22 Stockholm Ruotsi Tel 46 8 545 80 230
Sverige Orphan Europe AB Banérgatan 37 S-115 22 Stockholm Tel 46 8 545 80 230 Orphan Europe SARL Immeuble Le Wilson 70 avenue du Général de Gaulle F-92800 Puteaux 33 1 47 73 64 58
Latvija Orphan Europe AB Banérgatan 37 S-115 22 Stockholm Zviedrija Tel 46 8 545 80 230 United Kingdom Orphan Europe UK Ltd. Isis House, 43 Station Road Henley-on-Thames Oxfordshire RG9 1AT Tel 44 1491 414333
Lietuva
Orphan Europe AB
Banérgatan 37
S-115 22 Stockholm
?vedija
Tel: +46 8 545 80 230
This leaflet was last approved in
This medicine has been authorised under ?Exceptional Circumstances?.
This means that because of the rarity of this disease it has been impossible to get complete information on this medicine.
The European Medicines Agency (EMEA) will review any new information on the medicine every year and this leaflet will be updated as necessary.